[December 08, 2014]

Research and Markets: 2014-2018 US Transfusion Diagnostics Market: Supplier Shares, Sales Forecasts, Innovative Technologies, Competitive Strategies

Research and Markets (http://www.researchandmarkets.com/research/97222x/20142018_us) has announced the addition of the "2014-2018 US Transfusion Diagnostics Market: Supplier Shares, Sales Forecasts, Innovative Technologies, Competitive Strategies" report to their offering.

"2014 Opportunities in the US Blood Banking Market" is a new strategic analysis in order to help current suppliers and potential market entrants identify and evaluate emerging opportunities and assist industry executives in developing effective business, new product development and marketing strategies.

During the next five years, the US blood banking market is expected to undergo significant transformation, which will result from the convergence of several trends, including more stringent regulations; advances in diagnostic technologies, IT, system engineering and automation; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and differentiation are more critical than underlying technology.

The changes in the marketplace will create exciting opportunities for new instruments and reagent systems, as well as auxiliary products, such as specimen preparation devices, controls, calibrators, and innovative IT applications.

Strategic Recommendations

• New product development opportunities with significant market appeal.
• Alternative market penetration strategies.
• Potential market entry barriers and risks.

Blood Typing and Grouping Tests

• ABO, Antibody Panels, Antibody Screening/Indirect Antiglobulin,
• Antigen Typing (C, c, Duffy, E, e, I, i, Kell, Kidd, Le a, b, MN, P, S, s),
• Antiglobulin (Direct, C3 (News - Alert) + IgG, IgG, C3),
• Crossmatching (Immediate Spin, Full Crossmatch), Rh (D, Du).

Infectious Disease Screening Tests

• AIDS (HIV NAT, HIV-1/2), Cytomegalovirus,
• Hepatitis (HAV NAT, HBV NAT, HBs Ag,
• Anti-HBc, HCV NAT, HCV, ALT/SGPT), HTLV-I/II, Parvovirus B19 NAT,
• Syphilis, West Nile Virus NAT.

Sales and Market Share Analysis

• Sales and market share estimates of leading suppliers of blood banking of reagents and instruments, by individual product.

Competitive Assessments

• Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, and new products in R&D.

Market Segmentation Analysis

• Comprehensive market segmentation analysis, including review of the market dynamics, trends, structure, size, growth, and key suppliers.

Test volume and sales forecasts for over 40 blood banking tests, including NAT, by market segment:

• Blood Centers
• Hospitals
• Commercial/Private Laboratories

For more information visit http://www.researchandmarkets.com/research/97222x/20142018_us

[ Back To TMCnet.com's Homepage ]